What are the most common GLP-1 side effects, and which ones need medical attention?
Updated: 2026-09-09 · GLP-1 and weight
Short answer
The most frequent effects in the approved labels are digestive: nausea, vomiting, diarrhoea, constipation and abdominal pain. They usually show up early and often ease over time. The ones labels flag as reasons to seek care are the severe or persistent ones — especially strong ongoing abdominal pain, vomiting that stops you drinking, or signs of dehydration.
In plain English
- The typical pattern is gastrointestinal, because these drugs slow stomach emptying.
- Intensity varies a lot between people and does not predict whether the drug is 'working'.
- Labels carry warnings about pancreatitis, gallbladder problems and, in the US label, a boxed warning about thyroid tumours seen in rodents.
- None of this replaces the prescriber's assessment; this only describes what official documentation states.
What we know
- Nausea and other digestive symptoms are the most frequent adverse reactions in semaglutide and tirzepatide trials.
- Approved labels list warnings and contraindications explicitly.
- A share of people stop treatment because of digestive intolerance.
What we don't know yet
- There is no way to predict in advance who will tolerate it well.
- Very long-term, real-world data are still accumulating.
Educational information based on regulatory documentation. Not medical advice.
Sources
External links to official sources or peer-reviewed studies.